Friends: In honor of tomorrow’s Congressional Childhood Cancer Caucus Summit, we want to update you on the work we are doing. EXTENSION read more →
Creating Hope Act and Tropical Disease Vouchers Issued and Exercised Please see the CHA PRV vouchers table.
114th CONGRESS 2d Session H.R. 5858 To amend the Federal Food, Drug, and Cosmetic Act to establish a program read more →
By James Radke, PhD Last month, Congressman Michael McCaul spoke to the House of Representatives urging for the immediate reauthorization of read more →
Kids v Cancer welcomes NATURE’s editorial in support of the RACE for Children Act to champion the development of promising cancer drugs for children. read more →
RACE for Children Act will give children with cancer access to the most promising treatments. read more →
With drug companies’ policies hard to decipher, frustrated patients often resort to social-media campaigns and other public appeals. By Sara Reardon, Nature read more →
By Marcia Frellick As promised, the US Food and Drug Administration (FDA) has simplified the form physicians use to request investigational compassionate read more →
Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA Elena Gerasimov, Lindy Zhang, Scott Moerdler, Michael Roth, Nancy Goodman read more →
Kids v Cancer is proud to announce the launch of the Compassionate Use Navigator, a new service for the pediatric oncology community read more →
Introduced in Senate (07/28/2015) Advancing Hope Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to expand the read more →
Connecting Patients to New and Potential Life-Saving Treatments Thank you Chairman Johnson, Ranking Member Carper, and Members of the Committee for inviting read more →
By Sara Weber | Cronkite News When his family moved from Phoenix to London so he could get treatment for a potentially read more →
WASHINGTON, Feb. 19, 2016 /PRNewswire/ — Kids v Cancer received honors from Fast Company as #4 of the Top 10 Most Innovative Companies of read more →
Rare Pediatric Disease Priority Review Voucher Fee See Federal Register Notice.